Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures (Q39707630)

14 September 2017

title

Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures (English)

1 reference

14 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

Manuel Toledo

1 reference

14 September 2017

John Whitesides

1 reference

14 September 2017

Jimmy Schiemann

1 reference

14 September 2017

Martin E Johnson

1 reference

14 September 2017

Klaus Eckhardt

1 reference

14 September 2017

Belinda McDonough

1 reference

14 September 2017

Simon Borghs

1 reference

14 September 2017

Patrick Kwan

1 reference

14 September 2017

publication date

6 June 2016

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

1139-1151

1 reference

Drug treatment of epilepsy in adults

14 September 2017

cites work

1 reference

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity

21 January 2018

1 reference

Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.

21 January 2018

1 reference

Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial

21 January 2018

1 reference

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

21 January 2018

1 reference

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.

21 January 2018

1 reference

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

21 January 2018

1 reference

Patterns of treatment response in newly diagnosed epilepsy.

21 January 2018

1 reference

Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial

21 January 2018

1 reference

Healthcare utilization and costs in adults with stable and uncontrolled epilepsy

21 January 2018

1 reference

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

21 January 2018

1 reference

Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures

21 January 2018

1 reference

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

21 January 2018

1 reference

Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies

21 January 2018

1 reference

Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy

21 January 2018

1 reference

Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study

21 January 2018

1 reference

Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.

21 January 2018

1 reference

Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis

21 January 2018

1 reference

Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy

21 January 2018

1 reference

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death

21 January 2018

1 reference

Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being?

21 January 2018

1 reference

The effect of seizure severity on quality of life in epilepsy.

21 January 2018

1 reference

Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review

21 January 2018

1 reference

Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?

21 January 2018

1 reference

Determinants of quality of life in people with epilepsy

21 January 2018

1 reference

Patient-validated content of epilepsy-specific quality-of-life measurement.

21 January 2018

1 reference

Quality-of-life trajectories in epilepsy: a review of the literature

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EPI.13416

1 reference

14 September 2017

1 reference